Recent work has highlighted the tight coupling between the ER and the Cyclin D1-CDK4/6 pathways, thereby rendering ER+ breast cancers especially dependent upon CDK4/6 for proliferation[60]. The gene discussed is CCND1; the disease is breast carcinoma.